EMCDDA Home
  • EN
Search

Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2011 or most recent year available

Part (i) New clients by country and primary drug (%), regardless whether they inject the drug

CountryYearOpioidsCocaineAmphe taminesEcstasyCannabisHalluci nogensOthersDrug known (n)Drug unknown
Belgium1201118.013.611.21.048.20.17.922367
Bulgaria201193.21.41.70.33.10.00.329540
Czech Republic20119.90.369.60.118.70.01.4448626
Denmark20117.15.810.30.572.60.23.51444403
Germany2201119.26.215.20.054.90.24.21863713
Estonia201180.4:4.9:11.7:3.1163:
Ireland201039.013.30.90.635.70.110.437400
Greece201173.44.20.10.220.20.11.825684
Spain201018.245.31.20.232.30.22.6268050
France201120.25.10.30.271.10.22.9101231069
Italy3201142.430.30.10.525.20.11.42289910780
Cyprus201110.87.00.20.278.10.03.64431
Latvia4201134.10.328.20.019.81.116.536917
Lithuania2201172.10.82.0:3.60.021.5251:
Luxembourg::::::::::
Hungary20112.31.611.01.277.30.16.432220
Malta201145.428.4:1.620.8:3.818320
Netherlands20116.020.36.50.858.00.28.376710
Austria201141.37.63.51.241.80.44.31372216
Poland7201014.72.226.70.344.40.611.13604
Portugal5201154.414.40.10.225.40.05.51800465
Romania201129.61.60.90.611.30.855.211460
Slovenia201174.93.90.50.518.8:1.4207:
Slovakia201122.71.641.90.227.30.06.395483
Finland201143.80.011.60.832.90.010.82490
Sweden201016.51.719.40.545.10.216.6154948
United Kingdom6201040.016.03.60.332.40.77.0449842582
Croatia201129.82.62.20.552.70.611.61151:
Turkey201164.72.30.80.122.10.010.010840
Norway::::::::::
Total29.719.46.40.338.60.35.216039115778
 

Notes:

: Indicates no data available

Percentages are of clients whose primary drug is known (n).

Others substances include hypnotics and sedatives, volatile substances, other stimulants and other substances.

(1) In Belgium if the exact primary drug is not known, the generic category is recorded.

(2) Amphetamines refer to stimulants in general.

(3) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(4) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 onwards data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

(7) Category 'heroin' includes both heroin (brown and rarely appearing white) and so called 'kompot' (heroin gained from the poppy straws) still often used at the drug scene. The Polish TDI system has separate categories for heroin and 'kompot'. Additionally category 'amphetamines' includes both amphetamine and methamphetamine which are separate categories in Polish TDI.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2012 — TDI tables V. 1.0-2011 See Table TDI-0 for details on sources.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013